AbbVie Reconsiders $51.1B Shire Deal on Tax Deal

The video discusses AbbVie's strategic acquisition, highlighting its tax implications and market reactions. It examines the current state of M&A activity in the pharma sector, noting the challenges faced by companies like Astra and Medtronic. The focus then shifts to Qualcomm's strategy in the Internet of Things space, emphasizing the importance of connected devices. Finally, the video explores ARM's unique position in the semiconductor industry, discussing its design capabilities and market neutrality.

What was a significant factor in AbbVie's acquisition of Scheyer?

• Tax benefits

• Employee acquisition

• Product innovation

• Market expansion

Which company's deal in the pharmaceutical sector is mentioned as having a huge question mark?

• Astra

• Medtronic

• Shyer

• Alargan

What is the main focus of Qualcomm's acquisition of CSR?

• Artificial intelligence

• Mobile technology

• Internet of Things

• Cloud computing

What is unique about ARM compared to other semiconductor companies?

• They manufacture their own chips

• They are a neutral designer

• They focus on mobile technology

• They only work with Apple

What is a potential risk if a strategic player acquires ARM?

• Increased production costs

• Decreased market share

• Loss of design quality

• Loss of cross-selling ability